Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Faizyme Laboratories is a South Africa-based enzyme manufacturer focused on extracting and purifying enzymes from plant materials and animal organs for use in the diagnostic, pharmaceutical, and related industries. The company appears to operate primarily as a commercial supplier rather than a drug developer, with product offerings that include horseradish peroxidase and pancreatic enzymes such as trypsin, chymotrypsin, chymotrypsinogen, deoxyribonuclease, ribonuclease, hyaluronidase, and alkaline phosphatase. Available sources indicate the business was founded in 1994 and built capabilities around large-scale horseradish processing and peroxidase purification. Faizyme also appears to maintain GMP-compliant manufacturing and has been listed in third-party GMP audit directories. Overall, the company is best characterized as a niche life-science enzyme producer serving diagnostic and pharmaceutical manufacturers globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Faizyme Laboratories.